DaVita Launches Landmark Studies on Middle-Molecule Clearance in Kidney Failure Patients
Reuters
Oct 20
DaVita Launches Landmark Studies on Middle-Molecule Clearance in Kidney Failure Patients
DaVita Inc. has announced the launch of two new initiatives, MODEL and MEMOIRS, aimed at enhancing the understanding of middle-molecule removal in dialysis treatments for patients with end stage kidney disease (ESKD). These initiatives will collectively involve approximately 9,000 adults over the next two years. The MODEL initiative is a quality improvement project evaluating the survival of U.S. patients treated with medium cut-off dialyzers, while the MEMOIRS survey is a prospective cohort study comparing patient-reported outcomes between treatments using medium cut-off and high-flux dialyzers. The studies seek to generate first-of-its-kind U.S. data on the clinical outcomes and quality of life impacts of middle-molecule clearance. The results of these initiatives have not yet been presented.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DaVita Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA01427) on October 20, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.